Dustin M. Smith - Morgan Stanley Financial Advisor - Austin, TX
Morgan Stanley
Dustin M. Smith
Associate Vice President
Financial Advisor
Portfolio Manager
301 Congress Avenue Suite 1400
Austin, TX 78701
tel: (512) 474-1710
toll-free: (800) 234-1940 
fax: (512) 469-3408

As your Financial Advisor, I can help you define and strive to meet your goals by delivering a vast array of resources to you in the way that is most appropriate for how you invest and what you want to achieve. Working together I can help you to preserve and grow your wealth. You will have access to some of the world’s most seasoned and respected investment professionals, a premier trading and execution platform and a full spectrum of investment choices.

Services
  • Wealth Management
  • Alternative Investments
  • Commodities
  • Fixed Income
  • Precious Metals
  • 401(k) Rollovers
  • 529 Plans
  • Annuities
  • Asset Management
  • Business Succession Planning
  • Cash Management
  • Corporate Cash Management
  • Corporate Pension Funds
  • Corporate Retirement Plans
  • Defined Contribution Plans
  • Education Planning
  • Endowments and Foundations
  • Estate Planning Strategies
  • Exchange Traded Funds
  • Executive Benefit Services
  • Executive Financial Services
  • Financial Planning
  • Insurance Services
  • Life Insurance
  • Long Term Care Insurance
  • Municipal Bonds
  • Retirement Planning
  • Stock Option Plans
  • Structured Products
Education and Licensing
  • M.B.A. in Finance - University of Houston
  • B.S. - University of Utah

Bulletin Board
  • See September On the Markets from the Global Investment Committee featuring

    “Attitude Matters” Michael Wilson, chief investment officer of Morgan Stanley Wealth Management, says few investors believe the world can overcome the obstacles it faces. And this attitude, he adds, prevents them from seeing and acting on positive developments.

    “Say What? Biotech Is Cheaper Than Pharma?”  Historically, US biotechnology stocks have traded at a big premium to big European and US pharmaceutical companies because of their much faster growth rate. But now, for a variety of reasons, biotech is on a par with big pharma or even cheaper. Adam Parker, chief US equity strategist for Morgan Stanley & Co., explains how this anomalous behavior came to be.

    "Higher Oil Prices and Reforms Give MLPs a Lift"  Last year, midstream master limited partnerships faced a perfect storm of lower commodity prices, falling US hydrocarbon production and rising interest rates—and the results were brutal. Now, attractive valuation, higher energy prices and industry reforms give MLPs a brighter outlook, writes Vijay Chandar, market strategist for Morgan Stanley Wealth Management.

    • Plus, look for more on equities, fixed income and a Q&A with Morgan Stanley Investment Management’s Ruchir Sharma about the changing nature of the emerging markets. 

  • Reevaluate your investment strategy. For a free consultation, Request an Appointment or call me.

Check the background of our Firm and Investment Professionals on FINRA's BrokerCheck.

Dustin M. Smith holds the following registrations:
Securities Agent: AK, AR, AZ, CA, GA, IL, LA, MS, NY, PA, TN, TX, UT, VA; General Securities Representative; Investment Advisor Representative; Managed Futures

NMLS#: 1393531

This information, products and services described here are intended only for individuals residing in states where this Financial Advisor is properly registered as described in this site.
Morgan Stanley reserves the right, to the extent permitted under applicable law, to retain and monitor all electronic communications. Morgan Stanley will not accept purchase or sale orders via any Internet site, social media site and/or its messaging systems. Morgan Stanley does not endorse and is not responsible and assumes no liability for content, products or services posted by third-parties on any Internet site, social media site and/or its messaging systems. All electronic communications are subject to terms available at the following link: http://www.morganstanley.com/disclaimers/mssbemail.html. Any profiles and associated content are for U.S. residents only
*References to length of service at Morgan Stanley include years at Morgan Stanley and predecessor firms.
Morgan Stanley Smith Barney LLC and its affiliates do not provide tax or legal advice. Any such taxpayer should seek advice based on the taxpayer's particular circumstances from an independent tax advisor.
The securities/instruments, investments and investment strategies discussed in this material may not be suitable for all investors. The appropriateness of a particular investment or investment strategy will depend on an investor's individual circumstances and objectives. The views and opinions expressed on this website do not necessarily reflect those of Morgan Stanley.
Awards Disclosures

pp:6909 mp: 2281